Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Hepatocellular injury in a patient receiving pioglitazone.

Literature DB >> 11511159

Hepatocellular injury in a patient receiving pioglitazone.

K Maeda.

Abstract

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 2001 PMID： 11511159 DOI： 10.7326/0003-4819-135-4-200108210-00029

Source DB: PubMed Journal: Ann Intern Med ISSN： 0003-4819 Impact factor: 25.391

Keyword Cloud
Cited

× No keyword cloud information.

16 in total

1. Combined treatment with ursodeoxycholic acid and pioglitazone in a patient with NASH associated with type 2 diabetes and psoriasis.

Authors: Susumu Itoh; Azuma Kanazuka; Takahide Akimoto
Journal: Dig Dis Sci Date: 2003-11 Impact factor: 3.199

2. Cytotoxicity of 3-(3,5-dichlorophenyl)-2,4-thiazolidinedione (DCPT) and analogues in wild type and CYP3A4 stably transfected HepG2 cells.

Authors: Douglas M Frederick; Erina Y Jacinto; Niti N Patel; Thomas H Rushmore; Ruy Tchao; Peter J Harvison
Journal: Toxicol In Vitro Date: 2011-09-22 Impact factor: 3.500

Review 3. Important elements for the diagnosis of drug-induced liver injury.

Authors: Vijay K Agarwal; John G McHutchison; Jay H Hoofnagle
Journal: Clin Gastroenterol Hepatol Date: 2010-02-17 Impact factor: 11.382

Review 4. Pioglitazone: a review of its use in type 2 diabetes mellitus.

Authors: John Waugh; Gillian M Keating; Greg L Plosker; Stephanie Easthope; Dean M Robinson
Journal: Drugs Date: 2006 Impact factor: 9.546

5. Prediction of drug-induced liver injury using keratinocytes.

Authors: Rika Hirashima; Tomoo Itoh; Robert H Tukey; Ryoichi Fujiwara
Journal: J Appl Toxicol Date: 2017-01-31 Impact factor: 3.446

6. Effect of gender, dose, and time on 3-(3,5-dichlorophenyl)-2,4-thiazolidinedione (DCPT)-induced hepatotoxicity in Fischer 344 rats.

Authors: N N Patel; C M Crincoli; E L Kennedy; D M Frederick; R Tchao; P J Harvison
Journal: Xenobiotica Date: 2008-04 Impact factor: 1.908

Hepatocellular injury in a patient receiving pioglitazone.

1. Combined treatment with ursodeoxycholic acid and pioglitazone in a patient with NASH associated with type 2 diabetes and psoriasis.

2. Cytotoxicity of 3-(3,5-dichlorophenyl)-2,4-thiazolidinedione (DCPT) and analogues in wild type and CYP3A4 stably transfected HepG2 cells.

Review 3. Important elements for the diagnosis of drug-induced liver injury.

Review 4. Pioglitazone: a review of its use in type 2 diabetes mellitus.

5. Prediction of drug-induced liver injury using keratinocytes.

6. Effect of gender, dose, and time on 3-(3,5-dichlorophenyl)-2,4-thiazolidinedione (DCPT)-induced hepatotoxicity in Fischer 344 rats.

Review 7. Practical guidelines for diagnosis and early management of drug-induced liver injury.

8. Role of biotransformation in 3-(3,5-dichlorophenyl)-2,4-thiazolidinedione-induced hepatotoxicity in Fischer 344 rats.

Review 9. Treatment of PCOS with metformin and other insulin-sensitizing agents.

Review 10. Thiazolidinediones in type 2 diabetes mellitus: current clinical evidence.